The Microfluidic Technology market for Life Science research and In-Vitro Diagnostics applications has shown tremendous growth over the last few years. In order to reduce costs, different approaches have been taken depending on the application. For example, technologies used for Life Science and pharmaceutical research gravitate towards extremely high-density chips for multiplex testing. Conversely, Point-of-Care testing requires extremely low-cost disposable devices. But regardless of the approach, microfluidic chip cost depends strongly on production volume and feature size. Therefore, microfluidic players must find an optimum approach to materials selection and manufacturing technologies.
Many MEMS and Semicon industry players are looking for opportunities to enter the microfluidics field by leveraging their high-precision manufacturing capabilities and utilizing their ability to miniaturize and integrate “intelligence” on chips. However, this "race towards the nanometer" doesn't interest Life Science and IVD players, since the feature scales and sample size they require are dictated by the biology itself. The business case for silicon in microfluidics is thus linked to the following questions, which this webcast will address:
• Are there applications that truly need sub-micrometer miniaturization?
• Are there applications where the need for chip-level integration justifies a higher consumer price?
Frédéric Breussin is Business Unit Manager MEMS & Sensors. Expert in Microfluidics for diagnostics and life sciences, he has supported many companies in their innovation and product development strategy in making the bridge between micro systems technologies and their applications in Life sciences, diagnostics and medical device industries. He holds an Engineering diploma from INSA Rouen & a DEA in fluid mechanics from University of Rouen
Mike McLaughlin has been working with emerging technologies for over 12 years at IBM and Cisco and was a principal analyst at Gartner. He now leads all of Yole Développement's activities and business development for North America. Mike is a graduate of Stanford University in Palo Alto, CA